logo
'Sad Beige' Influencer Alleges Creator 'Stole Her Likeness.' Lawsuit Gets Major Update 1 Year After Filing

'Sad Beige' Influencer Alleges Creator 'Stole Her Likeness.' Lawsuit Gets Major Update 1 Year After Filing

Yahoo30-05-2025
The highly publicized "Sad Beige Lawsuit" is coming to a close, as both plaintiff Sydney Nicole Gifford and defendant Alyssa Sheil asked a judge to dismiss the case over a year after it was filed
In April 2024, Gifford brought on eight claims against Sheil, alleging that she "replicated" her "aesthetic" curated with neutral tones like beige and cream
Sheil denied all claims in her initial response, and after both parties requested to drop the case entirely, she celebrated setting a precedent to protect future "young influencers" against "bullying"In April 2024, Sydney Nicole Gifford filed a lawsuit alleging fellow influencer Alyssa Sheil "replicated" her "neutral, beige, and cream aesthetic" across various social media platforms. Over a year later, the two creators have asked a judge to dismiss the first-of-its-kind case, which has come to be known as the "Sad Beige Lawsuit."
Per the stipulation filed on Wednesday, May 28, both parties agreed to request the release of all Gifford's "claims and potential counterclaims" related to the initial action. Sheil's legal representation at AZA law firm issued a written statement confirming the dismissal of all eight claims brought on by the plaintiff, which included federal copyright infringement, vicarious copyright infringement, Digital Millennium Copyright Act violation, trade dress infringement and misappropriation.
According to the firm's statement, Sheil, 22, successfully motioned to dismiss three of Gifford's original claims in December 2024. Because the defendant already responded to the suit, Gifford, 25, needed Sheil's permission to surrender the case, which she obliged.
In a quote included by AZA, Sheil celebrated how the lawsuit's outcome might help protect creators from similar situations in the first place.
"This was about more than just me. This sets a precedent that young influencers can fight back and not give in to bullying,' said Sheil in the AZA statement. 'Ms. Gifford tried to intimidate me into leaving this industry. But she failed and the truth prevailed.'
Gifford's social media content centers around her home, fashion and the "must-have" items she finds on Amazon. Her posts consistently maintain a neutral-toned vibe, with content showcasing shades of brown and tan hues.
"I think I feel more calm in neutral spaces,' Gifford told The Verge in late November. 'Now my favorite color is beige," she added, which explains the hashtag she'll occasionally use on her content (#sadbeigehome). "It is a sad beige home, and I like it."
Like Gifford, Sheil made her name curating content that aligns with the beige aesthetic, and she regularly posts about her neutral-toned outfits, home decor and makeup routine.
"It's definitely very calming,' Sheil said of her decor when speaking with The Verge, who visited the Texas-based influencer for an interview a few days prior to meeting up with Gifford in her Minneapolis home. "I just want it to all be cohesive and plain."
According to the original filing from April 2024, which was obtained by PEOPLE, Gifford's lawsuit stated that she had been curating her "brand identity" and "credibility" online for five years. She claimed to have become known for her promotion of Amazon products, like apparel and household goods. She has "grown her business into a multi-thousand dollar operation," her lawsuit states.
Gifford and Sheil met in person in December 2022 with the intent to support each other's businesses, per the filing. It continues to state that after they got together in January 2023, Gifford blocked Sheil from viewing her content.
In August 2024, four months after Gifford's initial filing, attorneys for Sheil asked the U.S. District Court for the Western District of Texas to dismiss claims brought forth against her. Per the court documents, Sheil denied "every allegation" in the complaint.
"Sheil has never infringed on any work of Gifford's, because Sheil's work is independently developed, does not use anything belonging to Gifford, and is not based on anything posted by Gifford," the court document reads.
The response issued by Sheil's attorney claimed that the case stemmed from "jealousy." The documents note that when the two creators first met, Sheil was "younger and more successful on certain social media platforms that Gifford had not yet maximized."
The filings allege that "it was Gifford who asked Sheil" content-related questions, but Sheil did not seek out "a meritless lawsuit" claiming that Gifford "stole her likeness," read the court document
Sheil's legal team emphasized "the very nature" of the fashion and influencer industries: "Similar influencer content creators collaborate, adopt, and evolve on trends and looks to promote products to their audience and followers."
Read the original article on People
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

[Latest] Global Inferior Vena Cava IVC Filter Market Size/Share Worth USD 2,094.10 Million by 2034 at a 8.88% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT)
[Latest] Global Inferior Vena Cava IVC Filter Market Size/Share Worth USD 2,094.10 Million by 2034 at a 8.88% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT)

Yahoo

time11 minutes ago

  • Yahoo

[Latest] Global Inferior Vena Cava IVC Filter Market Size/Share Worth USD 2,094.10 Million by 2034 at a 8.88% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT)

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Inferior Vena Cava IVC Filter Market size & share revenue was valued at approximately USD 895.82 Million in 2024 and is expected to reach USD 974.16 Million in 2025 and is expected to reach around USD 2,094.10 Million by 2034, at a CAGR of 8.88% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Abbott, B. Braun Melsungen AG, Boston Scientific Corporation, Canon Medical Systems, Cardinal Health, Cook, Esaote SpA, General Electric Company, Hologic, Inc., Koninklijke Philips N.V., Samsung Healthcare, Shimadzu Corporation, Siemens Healthcare Private Limited, Stryker, Terumo Europe NV and others. Austin, TX, USA, July 23, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled 'Inferior Vena Cava IVC Filter Market Size, Trends and Insights By Product Type (Retrievable Inferior Vena Cava filters, Permanent Inferior Vena Cava Filters), By Material (Non-Ferromagnetic Material, Ferromagnetic Materials), By Application (Treatment of Venous Thromboembolism, Prevention of Pulmonary Embolism), By End Users (Hospitals, Ambulatory Surgical Centers, Emergency Care Centers), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034' in its research database. 'According to the latest research study, the demand of global Inferior Vena Cava IVC Filter Market size & share was valued at approximately USD 895.82 Million in 2024 and is expected to reach USD 974.16 Million in 2025 and is expected to reach a value of around USD 2,094.10 Million by 2034, at a compound annual growth rate (CAGR) of about 8.88% during the forecast period 2025 to 2034.' Click Here to Access a Free Sample Report of the Global Inferior Vena Cava IVC Filter Market @ Overview According to industry experts at CMI, the implementation of new strategies and technologies by manufacturers presents lucrative opportunities for players in the Inferior Vena Cava Filter Market during the forecast period. Furthermore, the growing significance of organized retailing is expected to drive the future growth of the market. Key Trends & Drivers Shift Toward Retrievable Filters: Given concerns about chronic complications engendered by permanent implants, we have a growing trend for the use of retrievable or temporary IVC filters. Physicians and patients prefer a device that can be pulled out as soon as the risk of an embolism has diminished, or if an undue adverse situation arises, including migration of filters, fracture, or perforation. Advances in retrieval techniques and follow-up protocols have resulted in enhanced success rates and thus a rising trend of clinical indications for retrieval. This appears to be the new trend supported by evolving clinical guidelines and regulatory agencies that promote retrieval, onward to manufacturers who innovate for a safer, easy-to-dispose filter that is application-wise beneficial for both temporary protection and long-term anesthetic. Technological Advancements in Filter Design: The new technologies offer one of the most important trends in the IVC filter market. The manufacturers are working on the next-generation filters with better biocompatibility along with the anti-migration properties and enhanced structural integrity. The better placement and retrievability are ensured via shape memory alloys such as nitinol, self-centring mechanisms, and non-ferromagnetic materials. Newer designs intend to lower the risk of thrombosis and trauma to the vena cava. These filters are getting safer and more effective, thereby building a lot of confidence amongst physicians to encourage their acceptance by different patient populations, including trauma, surgical, and oncology patients with varying thromboembolic risk. Rising Use of IVC Filters in Outpatient and Ambulatory Settings: The shift towards the outpatient care has resulted in the increased usage of the IVC filters in the ambulatory surgical centers (ASC) along with the outpatient departments (OPD). The minimally invasive filter placement procedures allow same-day discharge and are suitable for select non-emergency cases such as for scheduled surgery or cancer treatment. This explains the virtue of cost-efficiency, patient turnover, and hospital stays. Now that there is an international focus not only on the reduction of procedural costs but also on maintaining quality of care throughout, IVC filter procedures have become one of the few surgical interventions amenable to outpatient provision owing to which their potential for growth in usage and in the market in general is greater in developed countries with advanced ambulatory care infrastructure. Request a Customized Copy of the Inferior Vena Cava IVC Filter Market Report @ Increasing Awareness of Pulmonary Embolism and VTE Risks: The rising concerns among the healthcare workers along with the general public pertaining to venous thromboembolism (VTE) and pulmonary embolism (PE) has been augmenting the chances of early diagnosis and timely intervention. Educational activities, clinical training, and enhanced diagnostic imaging aid quick detection of patients at risk, especially in trauma, orthopedic, and oncology departments. This knowledge of the morbidity and mortality effects of PE has inclined more clinicians to search for IVC filters in justified cases. Being proactive, this consequently enlarges the patient base for these devices and prompts hospitals and clinics to stock them for emergency or elective filter placements. Expansion in Emerging Markets: Increasing acceptance of IVC filters is witnessed in emerging markets all through Asia-Pacific, Latin America, and parts of the Middle East and Africa, given the improvements in healthcare access, infrastructure, and awareness. Growing investment in public and private hospitals, medical tourism, and a burgeoning middle class are hence propelling the demand for better vascular interventions. Also, increasing incidences of lifestyle diseases and surgical operations in these regions predispose the development of anticoagulant-based treatment methods. International and regional players aim to capture these markets via low-cost, easy-to-install filter variants and through partnerships for localizing manufacturing and distribution. Integration of Digital Tracking and Follow-Up Systems: To cater the issue of the unretrieved temporary vascular filters, the integration of a digital tracking system and EHR alerts is increasingly being implemented for follow-up management. These systems remind the clinicians when filters have been placed, thereby allowing them to monitor when it needs to be retrieved or followed up and ensuring that the patient complies with it. The new approach improves patient outcomes, and fewer long-term complications set with the regulatory focus on retrieval monitoring. Increasingly, hospitals and device companies are adopting software tools and data-driven solutions to dish out improved procedural follow-up. This trend helps to enhance the safety and accountability of retrievable IVC filter use and encourage its responsible usage on a wider scale. Report Scope Feature of the Report Details Market Size in 2025 USD 974.16 Million Projected Market Size in 2034 USD 2,094.10 Million Market Size in 2024 USD 895.82 Million CAGR Growth Rate 8.88% CAGR Base Year 2024 Forecast Period 2025-2034 Key Segment By Product Type, Material, Application, End Users and Region Report Coverage Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends Regional Scope North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America Buying Options Request tailored purchasing options to fulfil your requirements for research. (A free sample of the Inferior Vena Cava IVC Filter report is available upon request; please contact us for more information.) Our Free Sample Report Consists of the following: Introduction, Overview, and in-depth industry analysis are all included in the 2024 updated report. The COVID-19 Pandemic Outbreak Impact Analysis is included in the package. About 220+ Pages Research Report (Including Recent Research) Provide detailed chapter-by-chapter guidance on the Request. Updated Regional Analysis with a Graphical Representation of Size, Share, and Trends for the Year 2025 Includes Tables and figures have been updated. The most recent version of the report includes the Top Market Players, their Business Strategies, Sales Volume, and Revenue Analysis Custom Market Insights (CMI) research methodology (Please note that the sample of the Inferior Vena Cava IVC Filter report has been modified to include the COVID-19 impact study prior to delivery.) Request a Customized Copy of the Inferior Vena Cava IVC Filter Market Report @ SWOT Analysis Strengths: IVC filters are highly effective in preventing acute pulmonary embolism (PE) in patients who have contraindications to anticoagulation (blood thinners) or in whom anticoagulation has failed. The increasing global prevalence of conditions like Deep Vein Thrombosis (DVT) and PE, driven by factors such as an aging population, rising rates of obesity, cancer, major surgeries, and prolonged immobility, directly fuels the demand for IVC filters as a preventive measure. Weakness: A significant weakness is the ongoing debate and concern from medical regulatory bodies (like the FDA) and studies regarding the long-term efficacy and potential complications of IVC filters, especially if left implanted for extended periods. Despite the shift to retrievable filters, actual retrieval rates remain 'inexplicably and unacceptably' low in many real-world scenarios. There is evidence of overuse and inappropriate placement of IVC filters in patients who could be adequately managed with anticoagulation, potentially exposing them to unnecessary risks without clear benefit. Opportunities: Continued public and professional awareness campaigns about VTE risks and preventive strategies will drive appropriate demand for IVC filters. Integration of AI-assisted imaging tools for more accurate placement and real-time monitoring of filter position and function can improve patient outcomes and increase adoption rates. Leveraging telemedicine and remote monitoring technologies for post-implantation follow-up can improve retrieval rates and reduce complications by ensuring timely intervention. Threats: Continued or increased regulatory warnings and tightening of guidelines based on new clinical evidence could further restrict the indications for IVC filter use, leading to a decline in implantation rates. As new and safer anticoagulants become available and physicians become more comfortable managing patients on these medications, the need for IVC filters may decrease, particularly in prophylactic settings. The Extensive media coverage of filter complications and lawsuits can lead to negative public perception, discouraging patients and physicians from considering IVC filters. Request a Customized Copy of the Inferior Vena Cava IVC Filter Market Report @ Key questions answered in this report: What is the size of the Inferior Vena Cava IVC Filter market and what is its expected growth rate? What are the primary driving factors that push the Inferior Vena Cava IVC Filter market forward? What are the Inferior Vena Cava IVC Filter Industry's top companies? What are the different categories that the Inferior Vena Cava IVC Filter Market caters to? What will be the fastest-growing segment or region? In the value chain, what role do essential players play? What is the procedure for getting a free copy of the Inferior Vena Cava IVC Filter market sample report and company profiles? Key Offerings: Market Share, Size & Forecast by Revenue | 2025−2034 Market Dynamics – Growth Drivers, Restraints, Investment Opportunities, and Leading Trends Market Segmentation – A detailed analysis by Types of Services, by End-User Services, and by regions Competitive Landscape – Top Key Vendors and Other Prominent Vendors Buy this Premium Inferior Vena Cava IVC Filter Research Report | Fast Delivery Available - [220+ Pages] @ Regional Analysis The Inferior Vena Cava IVC Filter Market is segmented into various regions, including North America, Europe, Asia-Pacific, and LAMEA. Here is a brief overview of each region: North America: North America holds a leading position in the Inferior Vena Cava IVC Filter Market due to its advanced healthcare infrastructure, high awareness of thromboembolic disorders, and widespread availability of interventional procedures. The region benefits from strong clinical guidelines, a high volume of surgeries, and a significant aging population—all contributing to increased demand for IVC filters. The United States represents the largest national market for Inferior Vena Cava IVC filters, driven by a high burden of venous thromboembolism, well-established hospital systems, and advanced interventional radiology capabilities. The country's strong emphasis on evidence-based care and early adoption of innovative medical technologies supports widespread use of both retrievable and permanent filters. Europe: Europe is a significant market for Inferior Vena Cava IVC filters, supported by a growing geriatric population and a steady rise in cardiovascular and thromboembolic disorders. Countries such as Germany, the UK, and France are at the forefront due to advanced healthcare systems and high awareness among clinicians. European regulatory frameworks, though strict, ensure patient safety and encourage the use of high-quality devices. Increasing adoption of minimally invasive procedures and greater integration of IVC filters in treatment protocols are driving demand. However, variations in healthcare access and reimbursement across the region pose moderate challenges to uniform market expansion. Asia-Pacific: The Asia-Pacific region is experiencing rapid growth in the Inferior Vena Cava IVC Filter Market, fueled by expanding healthcare infrastructure, a large at-risk population, and rising awareness of venous thromboembolism. Countries like China, India, and Japan are investing in advanced medical technologies and increasing the availability of interventional procedures. The growing burden of sedentary lifestyles, obesity, and aging populations further contributes to the rising incidence of pulmonary embolism. While cost sensitivity and regulatory diversity remain challenges, ongoing improvements in diagnostic and treatment capabilities are positioning Asia-Pacific as a high-potential market for both retrievable and permanent IVC filters. LAMEA: The LAMEA region presents emerging opportunities for the Inferior Vena Cava IVC Filter Market, driven by gradual improvements in healthcare access, rising incidence of thromboembolic diseases, and growing adoption of modern medical technologies. In Latin America, countries like Brazil and Mexico are seeing increased filter usage due to urbanization and the expansion of private healthcare. In the Middle East and Africa, rising investments in healthcare infrastructure and the growth of medical tourism are fostering market development. However, limited access to specialized care, lower awareness, and constrained healthcare budgets in several areas remain key challenges for widespread market penetration. Request a Customized Copy of the Inferior Vena Cava IVC Filter Market Report @ (We customized your report to meet your specific research requirements. Inquire with our sales team about customizing your report.) Still, Looking for More Information? Do OR Want Data for Inclusion in magazines, case studies, research papers, or Media? Email Directly Here with Detail Information: support@ Browse the full 'Inferior Vena Cava IVC Filter Market Size, Trends and Insights By Product Type (Retrievable Inferior Vena Cava filters, Permanent Inferior Vena Cava Filters), By Material (Non-Ferromagnetic Material, Ferromagnetic Materials), By Application (Treatment of Venous Thromboembolism, Prevention of Pulmonary Embolism), By End Users (Hospitals, Ambulatory Surgical Centers, Emergency Care Centers), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034' Report at List of the prominent players in the Inferior Vena Cava Filter Market: Abbott Braun Melsungen AG Boston Scientific Corporation Canon Medical Systems Cardinal Health Cook Esaote SpA General Electric Company Hologic Inc. Koninklijke Philips N.V. Samsung Healthcare Shimadzu Corporation Siemens Healthcare Private Limited Stryker Terumo Europe NV Others Click Here to Access a Free Sample Report of the Global Inferior Vena Cava IVC Filter Market @ Spectacular Deals Comprehensive coverage Maximum number of market tables and figures The subscription-based option is offered. Best price guarantee Free 35% or 60 hours of customization. Free post-sale service assistance. 25% discount on your next purchase. Service guarantees are available. Personalized market brief by author. Browse More Related Reports: Neoantigen Cancer Vaccine Market: Neoantigen Cancer Vaccine Market Size, Trends and Insights By Product (Personalised antigen vaccine, Off-the-shelf neoantigen vaccine), By Neoantigen Type (Synthetic Long Peptide, Nucleic acid, Dendritic cell, Tumour cell), By Route of Administration (Intravenous, Intramuscular, Transdermal), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034 Peptide Cancer Vaccine Market: Peptide Cancer Vaccine Market Size, Trends and Insights By Type (Multivalent Peptide Vaccine, Peptide Cocktail Type, Personalized Peptide Vaccine, Peptide-Pulsed Dendritic Cancer Vaccine, Hybrid Peptide Vaccine), By Application (Breast Cancer, Lung Cancer, Melanoma, Prostate Cancer), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034 US Pharmaceutical Drug Delivery Market: US Pharmaceutical Drug Delivery Market Size, Trends and Insights By Route of Administration (Oral, Ocular, Pulmonary, Nasal, Injectable, Topical, Other), By Application (Cardiovascular Diseases, Diabetes, Cancer, Infectious Diseases, Others), By End-user (Hospitals, Ambulatory Services, Home Healthcare), and By Region - Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034 High Flow Nasal Cannula Market: High Flow Nasal Cannula Market Size, Trends and Insights By Product Type (Single Heated Tube, Nasal Cannula, Active Humidifier, Air Blender), By Application (Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease, Acute Heart Failure, Others), By End User (Hospitals and Clinics, Ambulatory Care Centers, Long-term Care Centers, Others), By Sales Channel (Direct Channel, Indirect Channel), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025 – 2034 Non-invasive Brain Trauma Monitoring Device Market: Non-invasive Brain Trauma Monitoring Device Market Size, Trends and Insights By Product Type (Monitoring Devices, Consumables), By End-User (Hospitals, Neurological Centres, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025 – 2034 Burial Insurance Market: Burial Insurance Market Size, Trends and Insights By Coverage (Level Death Benefit, Guaranteed Acceptance, Modified or Graded Death Benefit), By End Use (Over 50, Over 60, Over 70, Over 80), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025 – 2034 Organoids and Spheroids Market: Organoids and Spheroids Market Size, Trends and Insights By Organoids Type (Neural Organoids, Hepatic Organoids, Intestinal Organoids, Other Organoids), By Spheroids Type (Multicellular Tumor Spheroids (MCTS), Neurospheres, Mammospheres, Hepatospheres, Embryoid Bodies), By Organoids Source (Primary Tissues, Stem Cells), By Spheroids Source (Cell Line, Primary Cell, iPSCs Derived Cells), By End User (BioSource and Pharmaceutical Industries, Academic & Research Institutes, Hospitals and Diagnostic Centers), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025 – 2034 Medical Education Market: Medical Education Market Size, Trends and Insights By Delivery Mode (Classroom-based Training, E-learning Solutions, Online Learning, Simulation-based Learning, AR/VR-based Training, AI-powered Learning), By End User Type (Medical Schools and Universities, Hospitals and Healthcare Organizations, Independent Training Institutes), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025 – 2034 Induced Pluripotent Stem Cell (iPSC) Market: Induced Pluripotent Stem Cell (iPSC) Market Size, Trends and Insights By Derived Cell Type (Hepatocytes, Fibroblasts, Keratinocytes, Amniotic Cells, Others), By Application (Drug Development, Tissue Engineering & Regenerative Medicine, Disease Modelling, Toxicology Research), By End-Use (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025 – 2034 The Inferior Vena Cava Filter Market is segmented as follows: By Product Type Retrievable Inferior Vena Cava filters Permanent Inferior Vena Cava Filters By Material Non-Ferromagnetic Material Ferromagnetic Materials By Application Treatment of Venous Thromboembolism Prevention of Pulmonary Embolism By End Users Hospitals Ambulatory Surgical Centers Emergency Care Centers Click Here to Get a Free Sample Report of the Global Inferior Vena Cava IVC Filter Market @ Regional Coverage: North America U.S. Canada Mexico Rest of North America Europe Germany France U.K. Russia Italy Spain Netherlands Rest of Europe Asia Pacific China Japan India New Zealand Australia South Korea Taiwan Rest of Asia Pacific The Middle East & Africa Saudi Arabia UAE Egypt Kuwait South Africa Rest of the Middle East & Africa Latin America Brazil Argentina Rest of Latin America This Inferior Vena Cava IVC Filter Market Research/Analysis Report Contains Answers to the following Questions. Which Trends Are Causing These Developments? Who Are the Global Key Players in This Inferior Vena Cava IVC Filter Market? What are Their Company Profile, Product Information, and Contact Information? What Was the Global Market Status of the Inferior Vena Cava IVC Filter Market? What Was the Capacity, Production Value, Cost and PROFIT of the Inferior Vena Cava IVC Filter Market? What Is the Current Market Status of the Inferior Vena Cava IVC Filter Industry? What's Market Competition in This Industry, Both Company and Country Wise? What's Market Analysis of Inferior Vena Cava IVC Filter Market by Considering Applications and Types? What Are Projections of the Global Inferior Vena Cava IVC Filter Industry Considering Capacity, Production and Production Value? What Will Be the Estimation of Cost and Profit? What Will Be Market Share, Supply and Consumption? What about imports and exports? What Is Inferior Vena Cava IVC Filter Market Chain Analysis by Upstream Raw Materials and Downstream Industry? What Is the Economic Impact On Inferior Vena Cava IVC Filter Industry? What are Global Macroeconomic Environment Analysis Results? What Are Global Macroeconomic Environment Development Trends? What Are Market Dynamics of Inferior Vena Cava IVC Filter Market? What Are Challenges and Opportunities? What Should Be Entry Strategies, Countermeasures to Economic Impact, and Marketing Channels for Inferior Vena Cava IVC Filter Industry? Click Here to Access a Free Sample Report of the Global Inferior Vena Cava IVC Filter Market @ Reasons to Purchase Inferior Vena Cava IVC Filter Market Report Inferior Vena Cava IVC Filter Market Report provides qualitative and quantitative analysis of the market based on segmentation involving economic and non-economic factors. Inferior Vena Cava IVC Filter Market report outlines market value (USD) data for each segment and sub-segment. This report indicates the region and segment expected to witness the fastest growth and dominate the market. Inferior Vena Cava IVC Filter Market Analysis by geography highlights the consumption of the product/service in the region and indicates the factors affecting the market within each region. The competitive landscape incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled. Extensive company profiles comprising company overview, company insights, product benchmarking, and SWOT analysis for the major market players. The Industry's current and future market outlook concerning recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging and developed regions. Inferior Vena Cava IVC Filter Market Includes in-depth market analysis from various perspectives through Porter's five forces analysis and provides insight into the market through Value Chain. Reasons for the Research Report The study provides a thorough overview of the global Inferior Vena Cava IVC Filter market. Compare your performance to that of the market as a whole. Aim to maintain competitiveness while innovations from established key players fuel market growth. Buy this Premium Inferior Vena Cava IVC Filter Research Report | Fast Delivery Available - [220+ Pages] @ What does the report include? Drivers, restrictions, and opportunities are among the qualitative elements covered in the worldwide Inferior Vena Cava IVC Filter market analysis. The competitive environment of current and potential participants in the Inferior Vena Cava IVC Filter market is covered in the report, as well as those companies' strategic product development ambitions. According to the component, application, and industry vertical, this study analyzes the market qualitatively and quantitatively. Additionally, the report offers comparable data for the important regions. For each segment mentioned above, actual market sizes and forecasts have been given. Who should buy this report? Participants and stakeholders worldwide Inferior Vena Cava IVC Filter market should find this report useful. The research will be useful to all market participants in the Inferior Vena Cava IVC Filter industry. Managers in the Inferior Vena Cava IVC Filter sector are interested in publishing up-to-date and projected data about the worldwide Inferior Vena Cava IVC Filter market. Governmental agencies, regulatory bodies, decision-makers, and organizations want to invest in Inferior Vena Cava IVC Filter products' market trends. Market insights are sought for by analysts, researchers, educators, strategy managers, and government organizations to develop plans. Request a Customized Copy of the Inferior Vena Cava IVC Filter Market Report @ About Custom Market Insights: Custom Market Insights is a market research and advisory company delivering business insights and market research reports to large, small, and medium-scale enterprises. We assist clients with strategies and business policies and regularly work towards achieving sustainable growth in their respective domains. CMI offers a comprehensive solution, from data collection to investment advice. Our company's expert analysis digs out essential factors that help us understand the significance and impact of market dynamics. The professional experts apply clients inside on the aspects such as strategies for future estimation fall, forecasting or opportunity to grow, and consumer survey. Follow Us: LinkedIn | Twitter | Facebook | YouTube Contact Us: Joel John CMI Consulting LLC 1333, 701 Tillery Street Unit 12, Austin, TX, Travis, US, 78702 USA: +1 737-734-2707 India: +91 20 46022736 Email: support@ Web: Blog: Blog: Blog: Blog: Buy this Premium Inferior Vena Cava IVC Filter Research Report | Fast Delivery Available - [220+ Pages] @

FFAI Marks Fourth Anniversary of Nasdaq Listing with Commitment to Accelerate FX Product Execution and Delivery, Uphold 'Stockholders First' Principle, and Continue the Counterattack Against Potential Illegal Short Selling
FFAI Marks Fourth Anniversary of Nasdaq Listing with Commitment to Accelerate FX Product Execution and Delivery, Uphold 'Stockholders First' Principle, and Continue the Counterattack Against Potential Illegal Short Selling

Business Wire

time12 minutes ago

  • Business Wire

FFAI Marks Fourth Anniversary of Nasdaq Listing with Commitment to Accelerate FX Product Execution and Delivery, Uphold 'Stockholders First' Principle, and Continue the Counterattack Against Potential Illegal Short Selling

LOS ANGELES--(BUSINESS WIRE)--Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) ('Faraday Future', 'FF' or the 'Company'), a California-based global shared intelligent electric mobility ecosystem company, today announced the celebration of its fourth anniversary as a publicly listed company on Nasdaq. Marking this milestone, the Company reaffirmed its commitment to driving breakthroughs in both its business and capital fundamentals. FF also pledged to accelerate the execution and delivery of products under its second brand, FX, while advancing its dual-brand strategy. Upholding its 'Stockholders First' philosophy, the Company remains focused on delivering greater value to stockholders by expediting efforts to win the Counterattack Against Potential Illegal Short Selling and maximizing stockholder interests. Faraday Future Marks Fourth Anniversary with a Reversal in Both Business and Capital Fundamentals Since its successful listing in 2021, FF has remained focused on disruptive innovation in the intelligent electric mobility ecosystem and is now advancing from the AIEV era to the next-generation EAI EV era. Following the return of the founding team—including Founder YT Jia—in April this year, the Company has implemented a comprehensive 'Ten Punch Combo' transformations, achieving a qualitative leap across key areas such as product development and delivery, manufacturing, supply chain, brand building, organizational governance, and system and capability buildup. On July 17, FF successfully unveiled in Downtown Los Angeles the FX Super One, alongside the Super EAI F.A.C.E. (Front AI Communication Ecosystem), and the FF EAI Embodied AI Agent 6x4 Architecture. The debut of the FX Super One made a striking market impression, fundamentally redefining the traditional luxury executive mobility experience long dominated by models such as the Cadillac Escalade. Compared to where the Company stood at the time of its IPO four years ago, FF has now achieved a dual turnaround in both business and capital fundamentals. The Company has established a strategic framework centered around dual home markets and dual DNA in U.S. and China, while also deploying its 'Third Pole' in Middle East. Through consistent delivery on its promises, more transparent communications, and a proactive and pragmatic corporate culture, FF has regained a vote of confidence from its stockholders. Since its debut, the FX Super One has attracted significant market attention, with over 10,000 paid pre-orders from both B2B and B2C customers. FF continues to refine its Co-Creation Ecosystem Online Direct Sales system, expand its multi-channel sales strategy, and elevate brand influence. The Company's 'B2B2C' co-creation ecosystem model now covers five core sectors: FX Par (Partners), car rental companies, live e-commerce MCN agencies, real estate brokerages, and home office industry. On July 21, the Company also announced a strategic partnership with HabitTrade, a global multi-market brokerage and digital asset infrastructure platform. Through this collaboration, FF seeks to build an integrated ecosystem combining EAI mobility, Web3, blockchain technology, crypto, and stablecoin applications. This initiative aims to bridge Web2 and Web3, connect on-chain and off-chain value flows, and expand the convergence between the real and virtual economies—creating new value for both users and the industry. In addition, the Company recently completed a new round of financing commitment totaling $105 million, which is expected to nearly cover the launch requirements of the FX Super One. Global institutional investor BlackRock has increased its holdings in FFAI for four consecutive quarters, reaching 5.39 million shares, signaling growing recognition and confidence among top-tier capital in the outlook of both FF and FX. Initial Victory in the Counterattack Against Potential Illegal Short Selling; FF Reaffirms Its Commitment to Protecting Stockholder Interests Since the appointment of Founder YT Jia as FF's Co-CEO, the Company has achieved initial success in its efforts to combat potential illegal short selling. The Company previously issued a public update on the identified illegal short selling and online market manipulation targeting FFAI, noting that certain individuals and online accounts involved had issued public apologies and taken down all content suspected of contributing to such manipulative activities. Recently, the Company identified additional indications of potential illegal short selling and the deliberate dissemination of false or misleading information aimed at disrupting the market. FF has issued a legal letter to the parties involved and reserves all rights to pursue legal remedies. On the occasion of its fourth anniversary as a publicly listed company, FF reaffirms its unwavering commitment to the 'Stockholders First' philosophy and its effort to continue to closely monitor the market for signs of potential illegal short selling and will take all necessary legal and regulatory actions to defend the rights and interests of its stockholders. Any attempts to undermine FFAI or harm investor interests will be met with appropriate consequences. FF also calls on regulators and the broader investment community to remain vigilant against such bad-faith efforts to distort capital markets. The Company urges collective resistance against the malicious attacks and defamatory campaigns launched by irresponsible entities targeting innovative enterprises. ABOUT FARADAY FUTURE Faraday Future is a California-based global shared intelligent electric mobility ecosystem company. Founded in 2014, the Company's mission is to disrupt the automotive industry by creating a user-centric, technology-first, and smart driving experience. Faraday Future's flagship model, the FF 91, exemplifies its vision for luxury, innovation, and performance. The FX strategy aims to introduce mass production models equipped with state-of-the-art luxury technology similar to the FF 91, targeting a broader market with middle-to-low price range offerings. FF is committed to redefining mobility through AI innovation. Join us in shaping the future of intelligent transportation. For more information, please visit FORWARD LOOKING STATEMENTS This press release includes 'forward looking statements' within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. When used in this press release, the words 'plan to,' 'can,' 'will,' 'should,' 'future,' 'potential,' and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements, which include statements regarding the Super One MPV, Super EAI F.A.C.E., and EAI Embodied AI Agent 6x4 architecture, are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the Company's control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Important factors, among others, that may affect actual results or outcomes include, among others: the Company's ability to secure necessary agreements to license or produce FX vehicles in the U.S., the Middle East, or elsewhere, none of which have been secured; the Company's ability to homologate FX vehicles for sale in the U.S., the Middle East, or elsewhere; the Company's ability to secure the necessary funding to execute on its AI, EREV and Faraday X (FX) strategies, each of which will be substantial; the Company's ability to secure necessary permits at its Hanford, CA production facility; the Company's ability to secure regulatory approvals for the proposed Super One front grill; the potential impact of tariff policy; the Company's ability to continue as a going concern and improve its liquidity and financial position; the Company's ability to pay its outstanding obligations; the Company's ability to remediate its material weaknesses in internal control over financial reporting and the risks related to the restatement of previously issued consolidated financial statements; the Company's limited operating history and the significant barriers to growth it faces; the Company's history of losses and expectation of continued losses; the success of the Company's payroll expense reduction plan; the Company's ability to execute on its plans to develop and market its vehicles and the timing of these development programs; the Company's estimates of the size of the markets for its vehicles and cost to bring those vehicles to market; the rate and degree of market acceptance of the Company's vehicles; the Company's ability to cover future warranty claims; the success of other competing manufacturers; the performance and security of the Company's vehicles; current and potential litigation involving the Company; uncertainties regarding the Company's legal remedies related to illegal short selling, market manipulation, or false information, and the unpredictability of judicial interpretations or regulatory responses; the Company's ability to receive funds from, satisfy the conditions precedent of and close on the various financings described elsewhere by the Company; the result of future financing efforts, the failure of any of which could result in the Company seeking protection under the Bankruptcy Code; the Company's indebtedness; the Company's ability to cover future warranty claims; the Company's ability to use its 'at-the-market' program; insurance coverage; general economic and market conditions impacting demand for the Company's products; potential negative impacts of a reverse stock split; potential cost, headcount and salary reduction actions may not be sufficient or may not achieve their expected results; circumstances outside of the Company's control, such as natural disasters, climate change, health epidemics and pandemics, terrorist attacks, and civil unrest; risks related to the Company's operations in China; the success of the Company's remedial measures taken in response to the Special Committee findings; the Company's dependence on its suppliers and contract manufacturer; the Company's ability to develop and protect its technologies; the Company's ability to protect against cybersecurity risks; and the ability of the Company to attract and retain employees, any adverse developments in existing legal proceedings or the initiation of new legal proceedings, and volatility of the Company's stock price. You should carefully consider the foregoing factors and the other risks and uncertainties described in the 'Risk Factors' section of the Company's Form 10-K filed with the SEC on March 31, 2025, and other documents filed by the Company from time to time with the SEC.

Texas Instruments Inc (TXN) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amid Market ...
Texas Instruments Inc (TXN) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amid Market ...

Yahoo

timean hour ago

  • Yahoo

Texas Instruments Inc (TXN) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amid Market ...

Revenue: $4.4 billion, up 9% sequentially and 16% year-over-year. Analog Revenue Growth: 18% year-over-year. Embedded Processing Growth: 10% year-over-year. Other Segment Growth: 14% year-over-year. Gross Profit: $2.6 billion, 58% of revenue. Operating Expenses: $1.0 billion, up 5% year-over-year. Operating Profit: $1.6 billion, 35% of revenue, up 25% year-over-year. Net Income: $1.3 billion, $1.41 per share. Cash Flow from Operations: $1.9 billion in the quarter. Capital Expenditures: $1.3 billion in the quarter. Free Cash Flow: $1.8 billion on a trailing 12-month basis. Dividends Paid: $1.2 billion in the quarter. Stock Repurchases: $302 million in the quarter. Total Debt: $14.15 billion with a weighted average coupon of 4%. Inventory: $4.8 billion, 231 days, down 9 days sequentially. Third Quarter Revenue Guidance: $4.45 billion to $4.80 billion. Third Quarter EPS Guidance: $1.36 to $1.60. Warning! GuruFocus has detected 11 Warning Signs with TXN. Release Date: July 22, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Revenue for the second quarter was $4.4 billion, marking a 9% sequential increase and a 16% year-over-year growth. Analog revenue grew 18% year-over-year, and embedded processing grew 10%, indicating strong performance in key segments. Enterprise systems revenue increased by about 40% year-over-year, showcasing significant growth in this sector. Gross profit margin improved by 110 basis points sequentially, reaching 58% of revenue. The company returned $6.7 billion to shareholders over the past 12 months through dividends and stock repurchases. Negative Points Automotive market revenue decreased slightly sequentially and showed only mid-single-digit growth year-over-year, indicating a slower recovery in this segment. The company issued $1.2 billion of debt, increasing total debt outstanding to $14.15 billion. Inventory levels increased to $4.8 billion, with days of inventory at 231, which could indicate potential overstocking. Guidance for the third quarter suggests a typical seasonal quarter with revenue growth of only 11%, which is lower than previous expectations. Concerns about tariffs and geopolitical uncertainties continue to impact supply chains, adding complexity to future planning. Q & A Highlights Q: Can you explain the change in tone regarding the cyclical recovery and the impact of tariffs on your outlook? A: Haviv Ilan, CEO, explained that while the cyclical recovery is ongoing, with four out of five markets showing recovery, the automotive market remains shallow. The geopolitical environment, including tariffs, continues to create uncertainty, necessitating flexibility in operations. The company is prepared to support customers despite these challenges. Q: Are you expecting gross margins to decline in the next quarter despite revenue growth? A: Rafael Lizardi, CFO, clarified that gross margins are expected to remain flat despite higher depreciation costs. The net of other income and expenses, including interest expenses, will be unfavorable by about $20 million due to lower cash levels and increased debt interest expenses. Q: How is the industrial segment performing, particularly in light of trade and tariff concerns? A: Mike Beckman, Head of Investor Relations, noted that the industrial segment showed broad recovery across all sectors, continuing the trend from the first quarter. The recovery was not significantly impacted by tariff concerns. Q: What is the outlook for capital expenditures and depreciation for the coming years? A: Rafael Lizardi stated that there are no changes to the CapEx and depreciation framework. For 2025, CapEx is expected to be $5 billion, and for 2026, it will range between $2 billion and $5 billion. Depreciation for 2025 is expected to be between $1.8 billion and $2 billion, and for 2026, between $2.3 billion and $2.7 billion. Q: How is the automotive market performing, particularly in China, and is there any share loss? A: Haviv Ilan explained that the automotive market in China ran hot last year, and current dynamics are more about inventory correction rather than share loss. The automotive market has not yet shown signs of broad recovery, but it is expected to follow the industrial market's recovery pattern. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store